Przemysław Niziński

Publication Activity (10 Years)

Years Active: 2023-2024
Publications (10 Years): 14

Top Topics

Top Venues

International journal of molecular sciences

Annals of medicine

This page only lists publications with an associated author ORCID identifier.

Publications

Agnieszka Ziółkiewicz, Przemysław Niziński, Jakub Soja, Tomasz Oniszczuk, Maciej Combrzyński, Adrianna Kondracka, Anna Oniszczuk
Potential of Chlorogenic Acid in the Management of Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD): Animal Studies and Clinical Trials-A Narrative Review. Metabolites 14 (6) (2024)
Jarosław Szponar, Przemysław Niziński, Jarosław Dudka, Kamila Kasprzak Drozd, Anna Oniszczuk
Natural Products for Preventing and Managing Anthracycline-Induced Cardiotoxicity: A Comprehensive Review. Cells 13 (13) (2024)
Kamila Kasprzak Drozd, Przemysław Niziński, Paulina Kasprzak, Adrianna Kondracka, Tomasz Oniszczuk, Agata Rusinek, Anna Oniszczuk
Does Resveratrol Improve Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD)? International journal of molecular sciences 25 (7) (2024)
Kamila Kasprzak Drozd, Przemysław Niziński, Paulina Kasprzak, Adrianna Kondracka, Tomasz Oniszczuk, Agata Rusinek, Anna Oniszczuk
Does Resveratrol Improve Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD)? International journal of molecular sciences 25 (7) (2024)
Agnieszka Ziółkiewicz, Przemysław Niziński, Jakub Soja, Tomasz Oniszczuk, Maciej Combrzyński, Adrianna Kondracka, Anna Oniszczuk
Potential of Chlorogenic Acid in the Management of Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD): Animal Studies and Clinical Trials-A Narrative Review. Metabolites 14 (6) (2024)
Agnieszka Ziółkiewicz, Przemysław Niziński, Jakub Soja, Tomasz Oniszczuk, Maciej Combrzyński, Adrianna Kondracka, Anna Oniszczuk
Potential of Chlorogenic Acid in the Management of Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD): Animal Studies and Clinical Trials-A Narrative Review. Metabolites 14 (6) (2024)
Kamila Kasprzak Drozd, Przemysław Niziński, Anna Hawrył, Gancarz Marek, Dominika Hawrył, Weronika Oliwa, Magdalena Pałka, Julia Markowska, Anna Oniszczuk
Potential of Curcumin in the Management of Skin Diseases. International journal of molecular sciences 25 (7) (2024)
Kamila Kasprzak Drozd, Przemysław Niziński, Paulina Kasprzak, Adrianna Kondracka, Tomasz Oniszczuk, Agata Rusinek, Anna Oniszczuk
Does Resveratrol Improve Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD)? International journal of molecular sciences 25 (7) (2024)
Jarosław Szponar, Przemysław Niziński, Jarosław Dudka, Kamila Kasprzak Drozd, Anna Oniszczuk
Natural Products for Preventing and Managing Anthracycline-Induced Cardiotoxicity: A Comprehensive Review. Cells 13 (13) (2024)
Jarosław Szponar, Przemysław Niziński, Jarosław Dudka, Kamila Kasprzak Drozd, Anna Oniszczuk
Natural Products for Preventing and Managing Anthracycline-Induced Cardiotoxicity: A Comprehensive Review. Cells 13 (13) (2024)
Kamila Kasprzak Drozd, Przemysław Niziński, Anna Hawrył, Gancarz Marek, Dominika Hawrył, Weronika Oliwa, Magdalena Pałka, Julia Markowska, Anna Oniszczuk
Potential of Curcumin in the Management of Skin Diseases. International journal of molecular sciences 25 (7) (2024)
Kamila Kasprzak Drozd, Przemysław Niziński, Anna Hawrył, Gancarz Marek, Dominika Hawrył, Weronika Oliwa, Magdalena Pałka, Julia Markowska, Anna Oniszczuk
Potential of Curcumin in the Management of Skin Diseases. International journal of molecular sciences 25 (7) (2024)
Michał Gil, Magdalena Knetki-Wroblewska, Przemysław Niziński, Maciej Strzemski, Paweł Krawczyk
Effectiveness of ALK inhibitors in treatment of CNS metastases in NSCLC patients. Annals of medicine 55 (1) (2023)
Michał Gil, Magdalena Knetki-Wroblewska, Przemysław Niziński, Maciej Strzemski, Paweł Krawczyk
Effectiveness of ALK inhibitors in treatment of CNS metastases in NSCLC patients. Annals of medicine 55 (1) (2023)